News

These findings were also replicated in other populations. 37,38 In addition, a GWAS study in 1.773 patients with CRC and 2,642 controls from East Asian reported that the C allele of rs4939827 SNP ...
The sensitive identification of single nucleotide polymorphisms becomes increasingly important for disease diagnosis, prevention, and practical applicability of pharmacogenomics. Herein, we propose a ...
Fifty years of outstanding neuroscience research studies have revealed many secrets of how drugs of abuse affect and change ...
Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO ...
Types of Weight Loss Drugs The Food and Drug Administration has approved several medications for chronic weight management. Below, compare different types of weight management drugs, how and when ...
It’s harder for Americans to get access to prescription drugs, even with insurance, research shows. Tori Marsh for GoodRx. June 17, 2025 at 11:30 AM. Copied; ...
Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.
Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move for a lot less money.
The leader of a drug organization that trafficked narcotics shaped like candy will spend nearly two decades behind bars, prosecutors said. Skip to content. NOWCAST News 9 at Noon.
Boltz-2 Released to Democratize AI Molecular Modeling for Drug Discovery. The AlphaFold 3 competitor from MIT predicts molecular binding affinity at unprecedented speed and accuracy, offering a ...
Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.
Border officials seized 50,000 kilos of Chinese precursor chemicals intended for Mexican cartels, part of China's broader strategy to undermine U.S. security.